function sa(url,headline_text,source,media_type,cluster,tagline,document_url,harvest_time,access_status,access_registration) 
{
   this.url = url;
   this.headline_text = headline_text;
   this.source = source;
   this.media_type = media_type;
   this.cluster = cluster;
   this.tagline = tagline;
   this.document_url = document_url;
   this.harvest_time = harvest_time;
   this.access_status = access_status;
   this.access_registration = access_registration;
}
article = new Array(
  new sa("http://click.pulse360.com/cgi-bin/clickthrough.cgi?db=context&position=7001&tid=bhnibmnlbnnobhnkbonozw&eid=1&id=92389170&creative=274181&query=general%20network%3A(general)&clickfactor_impression=1&clickid=87870965&UNQ=00000126578148811524072000000106050052&value=IUEGGRW3Z5SP2&origvalue=IUEGGRW3Z5SP2&cgroup=biotechnews","Email Marketing Software?","Sponsored Link","text","moreover..."," ","http://click.pulse360.com/cgi-bin/clickthrough.cgi?db=context&position=7001&tid=bhnibmnlbnnobhnkbonozw&eid=1&id=92389170&creative=274181&query=general%20network%3A(general)&clickfactor_impression=1&clickid=87870965&UNQ=00000126578148811524072000000106050052&value=IUEGGRW3Z5SP2&origvalue=IUEGGRW3Z5SP2&cgroup=biotechnews","10 Feb 2010 05:41:00"," "," "),
  new sa("http://c.moreover.com/click/here.pl?j2538395020","Voxeo partners with voice biometrics providers","Telecom Paper","text","moreover...","","http://feedproxy.google.com","10 Feb 2010 05:41:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538354908","Piramal Healthcare to foray into biotech sector","Moneycontrol.com","text","moreover...","","http://moneycontrol.com","10 Feb 2010 05:20:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538312762","GM food controversy in India","East African Standard","text","moreover...","","http://www.standardmedia.co.ke","10 Feb 2010 04:56:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538309253","India Rejects First GM Vegetable, Hampering Monsanto (Update1)","BusinessWeek","text","moreover...","","http://businessweek.com","10 Feb 2010 04:54:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538294981","Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await","BNet","text","moreover...","","http://feedproxy.google.com","10 Feb 2010 04:45:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538250607","Mansell Promoted to Manager, U.S. Fleet Services for Amgen USA","Fleet Financials","text","moreover...","","http://www.fleetfinancials.com","10 Feb 2010 04:18:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538200499","Amgen's denosumab offers hope in rare bone tumours","Yahoo! Malaysia","text","moreover...","","http://malaysia.news.yahoo.com","10 Feb 2010 03:46:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538186921","Biogen Beats & Guides Higher","Zacks.com","text","moreover...","","http://zacks.com","10 Feb 2010 03:37:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538167786","Biogen 4th-qtr profit up; outlook tops estimates","Reuters Health","text","moreover...","","http://reutershealth.com","10 Feb 2010 03:27:00","sub","http://www.reutershealth.com/en/subscribe.html"),
  new sa("http://c.moreover.com/click/here.pl?j2538159113","Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche","EurekAlert!","text","moreover...","","http://eurekalert.org","10 Feb 2010 03:22:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538153084","Biogen Tops Estimates on Solid Tysabri Sales; Challenges Ahead","Therapeutics Daily","text","moreover...","","http://www.therapeuticsdaily.com","10 Feb 2010 03:18:00","prem","http://www.therapeuticsdaily.com/register/index.cf"),
  new sa("http://c.moreover.com/click/here.pl?j2538152182","Activist Investor Pushes Celera to Divest Merck Bone Drug Royalties","Therapeutics Daily","text","moreover...","","http://www.therapeuticsdaily.com","10 Feb 2010 03:18:00","prem","http://www.therapeuticsdaily.com/register/index.cf"),
  new sa("http://c.moreover.com/click/here.pl?j2538143062","Amgen's denosumab offers hop","Selftrade Investments","text","moreover...","","http://selftrade.co.uk","10 Feb 2010 03:13:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538131138","Sequenom gets major licensing agreement","American Academy of Opthalmology","text","moreover...","","http://one.aao.org","10 Feb 2010 03:06:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538124657","Amgen (AMGN) Appears On Investors Observer Analysts Favorites List","Individual.com","text","moreover...","","http://individual.com","10 Feb 2010 03:03:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538059741","India says no to first GM food crop","The News International","text","moreover...","","http://thenews.com.pk","10 Feb 2010 02:25:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538057234","Biogen Idec Reports Full Year and Fourth Quarter 2009 Results","PipelineReview","text","moreover...","","http://pipelinereview.com","10 Feb 2010 02:24:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538040702","UK Court Affirms Invalidity Of Gene Patent In Lilly Suit","Law360","text","moreover...","","http://ip.law360.com","10 Feb 2010 02:15:00","sub","http://www.law360.com/subscribe"),
  new sa("http://c.moreover.com/click/here.pl?j2538021294","Cephalon Bullish Moving Average Crossover Alert  (CEPH)","Individual.com","text","moreover...","","http://individual.com","10 Feb 2010 02:04:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2538020546","Genzyme Names Ex-Lilly Exec to Head Manufacturing","Pharmaceutical Manufacturing Magazine","text","moreover...","","http://pharmamanufacturing.com","10 Feb 2010 02:04:00","","")
);